chr3-185192304-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP7BS2
The NM_001966.4(EHHADH):āc.2094A>Gā(p.Leu698=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000396 in 1,614,084 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00041 ( 0 hom., cov: 32)
Exomes š: 0.00039 ( 2 hom. )
Consequence
EHHADH
NM_001966.4 synonymous
NM_001966.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0300
Genes affected
EHHADH (HGNC:3247): (enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase) The protein encoded by this gene is a bifunctional enzyme and is one of the four enzymes of the peroxisomal beta-oxidation pathway. The N-terminal region of the encoded protein contains enoyl-CoA hydratase activity while the C-terminal region contains 3-hydroxyacyl-CoA dehydrogenase activity. Defects in this gene are a cause of peroxisomal disorders such as Zellweger syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP7
Synonymous conserved (PhyloP=0.03 with no splicing effect.
BS2
High AC in GnomAd4 at 62 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EHHADH | NM_001966.4 | c.2094A>G | p.Leu698= | synonymous_variant | 7/7 | ENST00000231887.8 | NP_001957.2 | |
EHHADH | NM_001166415.2 | c.1806A>G | p.Leu602= | synonymous_variant | 7/7 | NP_001159887.1 | ||
EHHADH | XM_047447640.1 | c.1470A>G | p.Leu490= | synonymous_variant | 5/5 | XP_047303596.1 | ||
EHHADH | XM_047447641.1 | c.1470A>G | p.Leu490= | synonymous_variant | 4/4 | XP_047303597.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EHHADH | ENST00000231887.8 | c.2094A>G | p.Leu698= | synonymous_variant | 7/7 | 1 | NM_001966.4 | ENSP00000231887 | P1 | |
EHHADH | ENST00000456310.5 | c.1806A>G | p.Leu602= | synonymous_variant | 7/7 | 2 | ENSP00000387746 |
Frequencies
GnomAD3 genomes AF: 0.000407 AC: 62AN: 152198Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
62
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000422 AC: 106AN: 250974Hom.: 1 AF XY: 0.000413 AC XY: 56AN XY: 135734
GnomAD3 exomes
AF:
AC:
106
AN:
250974
Hom.:
AF XY:
AC XY:
56
AN XY:
135734
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000395 AC: 577AN: 1461886Hom.: 2 Cov.: 31 AF XY: 0.000400 AC XY: 291AN XY: 727244
GnomAD4 exome
AF:
AC:
577
AN:
1461886
Hom.:
Cov.:
31
AF XY:
AC XY:
291
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000407 AC: 62AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74344
GnomAD4 genome
AF:
AC:
62
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
23
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 02, 2017 | - - |
EHHADH-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 10, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at